What is Nano-X Imaging Ltd. (NNOX)?

Nano-X Imaging Ltd. (NNOX) is a stock in the Healthcare sector, Medical - Devices industry. View full analysis on Stocks360.

What is the current price of NNOX?

The current price of NNOX is $0.32. Prices are updated in real time on Stocks360.

What is NNOX's price-to-earnings (PE) ratio?

NNOX's trailing twelve-month PE ratio is -0.19, based on current price and earnings per share data available on Stocks360.

What is NNOX's market capitalization?

NNOX's market capitalization is $25,250,517.00, placing it in the small-cap tier.

Nano-X Imaging Ltd. (NNOX)

Stock analysis · NASDAQ · Healthcare · Medical - Devices

$0.32

Market Cap

$25.25M

PE (TTM)

-0.19

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

1.26

Day Range

$0.32 – $0.33

52-wk Range

$0.32 – $4.71

Avg Volume

N/A

Volume

697.50K

Nano-X Imaging Ltd. (NNOX) is a publicly traded company in the Healthcare sector. Latest price: $0.32. Market cap $25.25M. Trailing PE -0.19. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-29 · $3.74 2026-10-28 · $0.32 (-91.41%)

Earnings

Most Recent

Sep 9, 2026

EPS $-0.79 vs est. $-0.16

Missed by $0.63

Next Earnings

Nov 19, 2026

EPS estimate $-0.15

Proprietary Signals

Signal snapshot temporarily unavailable.

About Nano-X Imaging Ltd.

Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.19×
P/S (TTM)	1.62×
P/B	0.31×
PEG	0.00×
P/FCF (TTM)	-0.47×
EV / EBITDA	-0.02×
EV / Sales	0.13×
Earnings Yield	-519.87%
Free Cash Flow Yield	-211.01%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$1.95M
Revenue (TTM)	$15.63M
Net Income (TTM)	-$131.27M
Free Cash Flow (TTM)	-$53.28M
Net Debt	-$23.30M
Working Capital	$25.27M
Gross Margin	-338.20%
Operating Margin	-654.94%
Net Margin	-747.20%
Return on Equity	-94.35%
Return on Invested Capital	-123.96%